Search

Your search keyword '"Fukahori M"' showing total 150 results

Search Constraints

Start Over You searched for: Author "Fukahori M" Remove constraint Author: "Fukahori M"
150 results on '"Fukahori M"'

Search Results

101. Effect of patient positioning on carbon-ion therapy planned dose distribution to pancreatic tumors and organs at risk.

102. Effect of epicuticular wax crystals on the localization of artificially deposited sub-micron carbon-based aerosols on needles of Cryptomeria japonica.

103. A phase I study of the combination of panitumumab and bevacizumab in KRAS wild-type colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, irinotecan and bevacizumab.

104. Modelling of organ-specific radiation-induced secondary cancer risks following particle therapy.

105. Histoanatomical characteristics to increase the success in transoral surgery for hypopharyngeal cancer.

106. mFOLFOX6 Chemotherapy after Resection of Anal Canal Mucinous Adenocarcinoma.

107. Successful Treatment of Metastatic Anal Canal Adenocarcinoma with mFOLFOX6 + Bevacizumab.

108. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.

109. CT images of enterohaemorrhagic Escherichia coli colitis.

110. Regeneration of Vocal Fold Mucosa Using Tissue-Engineered Structures with Oral Mucosal Cells.

111. Estimation of late rectal normal tissue complication probability parameters in carbon ion therapy for prostate cancer.

112. Trousseau's syndrome in a patient with gastric cancer.

113. [Trends in vocal cord surgery].

115. Origin of Vocal Fold Stellate Cells in the Human Macula Flava.

116. A case of silent perforated diverticulitis in the ascending colon combined with pylephlebitis resulting in complete occlusion of the portal trunk.

117. Left-sided inferior vena cava.

118. Successful treatment with s-1 and oxaliplatin combination therapy in an elderly patient with metastatic colorectal cancer initially presenting with membranous nephropathy.

119. Application of a radiophotoluminescent glass dosimeter to nonreference condition dosimetry in the postal dose audit system.

120. A new method for tracking organ motion on diagnostic ultrasound images.

121. Effect of corn steep liquor on lettuce root rot (Fusarium oxysporum f.sp. lactucae) in hydroponic cultures.

122. Analysis of passive motion of para- and retropharyngeal structures during swallowing using dynamic magnetic resonance imaging.

123. Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer.

124. Surgical management for isolated cricoid fracture causing arytenoid immobility.

125. Quality evaluation of medicinal products and health foods containing chaste berry (Vitex agnus-castus) in Japanese, European and American markets.

126. [Effects of liver hydrolysate on the blood glucose in metabolic syndrome model rats (SHR/NDmcr-cp)].

127. [Analysis of the components of porcine liver hydrolysate and examination of the antioxidant activity and angiotensin converting enzyme (ACE)-inhibiting activity].

128. Liver hydrolysate assists in the recovery from physical fatigue in a mouse model.

129. The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort.

130. [Development of the 60Co gamma-ray standard field for therapy-level dosimeter calibration in terms of absorbed dose to water (N(D,w))].

131. [Clinical efficacy and safety of CPT-11+CDDP therapy as third-line chemotherapy for advanced and recurrent gastric cancer].

132. [Three cases of advanced gastric cancer successfully treated by combination therapy of biweekly S-1 and docetaxel].

133. [A case of advanced gastric cancer successfully treated by combination therapy of S-1 and docetaxel].

134. Phase II study of weekly paclitaxel as a second-line treatment for S-1-refractory advanced gastric cancer.

135. [A case of metastatic breast cancer with liver metastasis effectively treated with capecitabine and vinorelbine].

136. [A case of cardioembolic brain infarction in arrhythmogenic right ventricular dysplasia].

137. Characteristic clinical findings of reversible left ventricular dysfunction.

138. Enhanced absorption of calcium after oral administration of maltitol in the rat intestine.

139. Early reperfusion induces alveolar injury in pulmonary embolism.

140. Effects of the structures of polyoxyethylene alkyl ethers on uptake of butyl p-hydroxybenzoate by Escherichia coli and its antibacterial activity.

141. Relationship between uptake of p-hydroxybenzoic acid esters by Escherichia coli and antibacterial activity.

142. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia.

143. [Results of annual health examination for the aged provided by the law that are predictive of increased mortality risk].

144. Nitric oxide reversibly suppresses xanthine oxidase activity.

145. The reactions of 3,5-dibromo-4-nitrosobenzenesulfonate and its biological applications.

146. Purification of endogenous inhibitors of [3H]flunitrazepam binding from bovine brain.

147. [3H]MK-801 binding to forebrain of E1 (epileptic) and non-epileptic strains of mice.

148. Effects of dietary zinc status on seizure susceptibility and hippocampal zinc content in the El (epilepsy) mouse.

149. Zinc content in discrete hippocampal and amygdaloid areas of the epilepsy (El) mouse and normal mice.

150. Behavior of lead and zinc in plasma, erythrocytes, and urine and ALAD in erythrocytes following intravenous infusion of CaEDTA in lead workers.

Catalog

Books, media, physical & digital resources